[EN] HETEROCYCLIC COMPOUNDS AS BET INHIBITORS<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES UTILISÉS EN TANT QU'INHIBITEURS DE BET
申请人:NUVATION BIO INC
公开号:WO2021003310A1
公开(公告)日:2021-01-07
Novel bromodomain and extraterminal domain (BET) inhibitors and to therapeutic methods of treating conditions and diseases using these novel BET inhibitors are provided.
Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors
申请人:NUVATION BIO INC.
公开号:US11192900B2
公开(公告)日:2021-12-07
Novel bromodomain and extraterminal domain (BET) inhibitors contanining substituted 2-pyridones and therapeutic methods of treating conditions and diseases using these novel BET inhibitors are provided.
本研究提供了含有取代的 2-吡啶酮的新型溴结构域和外结构域(BET)抑制剂,以及使用这些新型 BET 抑制剂治疗病症和疾病的方法。
Jacquesy, Jean-Claude; Jouannetaud', Marie-Paulf, Bulletin de la Societe Chimique de France, 1980, vol. 2, # 5-6, p. 267 - 274
JACQESY J.-C.; JOUANNETAUD M.-P., BULL. SOC. CHIM. FRANCE, 1980. PART 2, NO 5-6, 267-274
作者:JACQESY J.-C.、 JOUANNETAUD M.-P.
DOI:——
日期:——
HETEROCYCLIC COMPOUNDS AS BET INHIBITORS
申请人:NUVATION BIO INC.
公开号:US20200140459A1
公开(公告)日:2020-05-07
Novel bromodomain and extraterminal domain (BET) inhibitors and to therapeutic methods of treating conditions and diseases using these novel BET inhibitors are provided.